If your Part D costs are prohibitive, options include switching to a Part D plan with better Ozempic coverage during open enrollment, applying for Medicare Extra Help (Low Income Subsidy) if you qualify, or using the cash-pay pricing at $349 monthly (paying out of pocket instead of using Medicare)
Fatigue : Some individuals report feeling more tired than usual, particularly during the first few weeks of treatment
In this context, GLP-1 receptor agonists represent one of the most promising pharmacological classes, particularly if challenges related to cost, equitable access, reimbursement policy, and supply constraints are addressed
use calendar alerts so dose timing isnt the reason you feel off
However, a meta-analysis of studies indicates that patient tolerability and preference often lean towards the injectable form due to its less frequent dosing schedule